Zobrazeno 1 - 10
of 12
pro vyhledávání: '"S. P. Rawson"'
Autor:
Catherine Y. Lau, Nigel S. B. Rawson
Publikováno v:
Current Oncology, Vol 31, Iss 9, Pp 5599-5607 (2024)
Canada is known to have a complex pathway for new drug approval and reimbursement, resulting in delayed access for patients with serious and life-threatening diseases, such as cancer. Several recent publications from key stakeholders, including patie
Externí odkaz:
https://doaj.org/article/f93c407c05234ae4a935cd5827261ee2
Autor:
David J. Stewart, John-Peter Bradford, Sandeep Sehdev, Tim Ramsay, Vishal Navani, Nigel S. B. Rawson, Di Maria Jiang, Joanna Gotfrit, Paul Wheatley-Price, Geoffrey Liu, Alan Kaplan, Silvana Spadafora, Shaun G. Goodman, Rebecca A. C. Auer, Gerald Batist
Publikováno v:
Current Oncology, Vol 31, Iss 5, Pp 2453-2480 (2024)
Countries face challenges in paying for new drugs. High prices are driven in part by exploding drug development costs, which, in turn, are driven by essential but excessive regulation. Burdensome regulation also delays drug development, and this can
Externí odkaz:
https://doaj.org/article/e2a0bda42f934ee6ba8bb491b5743aa9
Autor:
Sandeep R. Sehdev, Nigel S. B. Rawson, Olexiy I. Aseyev, Catriona J. Buick, Marcus O. Butler, Scott Edwards, Sharlene Gill, Joanna M. Gotfrit, Cyrus C. Hsia, Rosalyn A. Juergens, Mita Manna, Joy S. McCarthy, Som D. Mukherjee, Stephanie L. Snow, Silvana Spadafora, David J. Stewart, Jason R. Wentzell, Ralph P. W. Wong, Pawel G. Zalewski
Publikováno v:
Current Oncology, Vol 31, Iss 4, Pp 1803-1816 (2024)
Patient access to new oncology drugs in Canada is only possible after navigating multiple sequential systemic checkpoints for national regulatory approval, health technology assessment (HTA) and collective government price negotiation. These steps de
Externí odkaz:
https://doaj.org/article/3be7b57ba6b54e2e8cadf719163522c8
Autor:
Nigel S. B. Rawson
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Background Since 2014, the Canadian Agency for Drugs and Technologies in Health (CADTH), which performs health technology assessments for all federal, provincial and territorial government drug programs (except Quebec’s) and the pan-Canadi
Externí odkaz:
https://doaj.org/article/b5e03201575f4acc94e545769874da8a
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Cellular materials are recognized for their high specific mechanical properties, making them desirable in ultra-lightweight applications. Periodic lattices have tunable properties and may be manufactured by metallic additive manufacturing (A
Externí odkaz:
https://doaj.org/article/7fd7935efad6499caca7a32a07a2d601
Autor:
Nigel S. B. Rawson
Publikováno v:
International Journal of Health Policy and Management, Vol 9, Iss 12, Pp 524-527 (2020)
Canada’s federal government intends to take steps to implement national pharmacare so that all Canadians have prescription drug coverage they need at an affordable price. Relatively limited funds have so far been pledged to support national pharmac
Externí odkaz:
https://doaj.org/article/a67a782beedd4b1eac23299253ac21fe
Autor:
Nigel S. B. Rawson
Publikováno v:
Frontiers in Public Health, Vol 8 (2020)
Introduction: Canada may soon see the introduction of a national pharmaceutical insurance system. New Zealand has a government-funded healthcare system used by all residents that operates within a tight cost-containment budget. The objective of this
Externí odkaz:
https://doaj.org/article/50d18d5748584510a6d14fd21d609bfc
Autor:
Nigel S. B. Rawson
Publikováno v:
Israel Journal of Health Policy Research, Vol 6, Iss 1, Pp 1-3 (2017)
Abstract Non-adherence to medication regimens is a major issue that can negatively impact patient health and wastes health care system resources. This commentary considers whether approaches to strategies undertaken in Israel to promote adherence cou
Externí odkaz:
https://doaj.org/article/d0dea815b9844ba4970bd1be2d34db3d
Publikováno v:
Pediatric Radiology. 2:51-59
The radiological status of fifty patients with rheumatoid arthritis was re-evaluated in a follow-up study ranging from 1–30 years. A skeletal survey was compared with the radiographs taken at the onset of the disease and changes were graded accordi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c02f903ab05ba4cf0d6d467eabeadea1
https://doi.org/10.1007/bf00972848
https://doi.org/10.1007/bf00972848
Autor:
S. P. Rawson
Publikováno v:
Proceedings of the Royal Society of Medicine. 49:269-274
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7019ecf929ed79e738f852243bb94883
https://doi.org/10.1177/003591575604900507
https://doi.org/10.1177/003591575604900507